Advertisement

#Novartis

CDK4/6 Inhibitors Show Promise for Multiple Cancer Types

A study in mice suggests that therapies approved for breast cancer may also combat other types, including colorectal and stomach cancer.

Tafinlar

Mekinist

FDA Issues Warning About Ibrance, Kisqali, Verzenio Due to Lung Inflammation

The FDA is warning that these drugs used to treat advanced breast cancers may cause rare but severe inflammation of the lungs.

Zykadia

44 States Sue 20 Makers of Generic Drugs Over Alleged Price Fixing

At the center of the lawsuit is Teva Pharmaceutical, slated to sell a generic version of the HIV prevention pill PrEP next year.

Kisqali

Kisqali Improves Outcomes for Premenopausal Women With Advanced Breast Cancer

CDK4/6 inhibitor plus hormone therapy extends progression-free survival for younger women.

A patient’s T cells arrive at the Novartis manufacturing facility in Morris Plains, where they will be re-engineered to recognize and fight cancer and healthy cells expressing a specific antigen in the patient’s body.

FDA Committee Recommends New Gene Therapy for Leukemia in Children

CAR-T therapy CTL019 trains immune system to recognize and fight cancer cells.

Advertisement